Matrix metalloproteinases A review of their structure and role in acute coronary syndrome

scientific article published on October 1, 2003

Matrix metalloproteinases A review of their structure and role in acute coronary syndrome is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/S0008-6363(03)00516-9
P953full work available at URLhttp://academic.oup.com/cardiovascres/article-pdf/59/4/812/7522413/59-4-812.pdf
https://academic.oup.com/cardiovascres/article-pdf/59/4/812/7522413/59-4-812.pdf
P698PubMed publication ID14553821

P2093author name stringCharles B. Jones
David C. Sane
David M. Herrington
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectphysiologyQ521
acute coronary syndromeQ266018
Cardiology and cardiovascular medicineQ96320350
P304page(s)812-823
P577publication date2003-10-01
P1433published inCardiovascular ResearchQ4642329
P1476titleMatrix metalloproteinases: a review of their structure and role in acute coronary syndrome
Matrix metalloproteinases A review of their structure and role in acute coronary syndrome
P478volume59

Reverse relations

cites work (P2860)
Q449800468-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells
Q38145567A platelet-inspired paradigm for nanomedicine targeted to multiple diseases
Q35072984A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"
Q37765287A timely diagnosis of myocardial infarction.
Q87418481Adhesion molecule CD146 and its soluble form correlate well with carotid atherosclerosis and plaque instability
Q35205043Association between the MMP-9-1562 C>T polymorphism and the risk of stroke: a meta-analysis
Q35709244Association of Matrix Metalloproteinase 9 C-1562T Polymorphism with Genetic Susceptibility to Myocardial Infarction: A Meta-Analysis
Q28283856Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population
Q37578262Beta-adrenoceptor Activation by Norepinephrine Enhances Lipopolysaccharide-induced Matrix Metalloproteinase-9 Expression Through the ERK/JNK-c-Fos Pathway in Human THP-1 Cells
Q23918414Biomarkers of World Trade Center particulate matter exposure: physiology of distal airway and blood biomarkers that predict FEV1 decline
Q36114066Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.
Q33797629Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function
Q36760539COX-2 and the vasculature: angel or evil?
Q37105193Cardiovascular inflammation
Q46734616Carnosic acid prevents the migration of human aortic smooth muscle cells by inhibiting the activation and expression of matrix metalloproteinase-9.
Q46878280Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
Q45166020Decreased expression of matrix metalloproteinase-9 and increased expression of tissue inhibitors of matrix metalloproteinase-1 in paratuberculosis-infected cattle in the ELISA-negative subclinical stage
Q36403328Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling
Q37681570Development of an aptamer-conjugated fluorescent nanoprobe for MMP2.
Q23921517Early elevation of serum MMP-3 and MMP-12 predicts protection from World Trade Center-lung injury in New York City firefighters: a nested case-control study
Q39277240Effect of Rosemarinus officinalis L. on MMP-9, MCP-1 levels, and cell migration in RAW 264.7 and smooth muscle cells
Q46911133Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients
Q30409097Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery.
Q36095176Expression and correlation of matrix metalloproteinase-7 and interleukin-15 in human osteoarthritis
Q53062247Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis.
Q89617856Feeling Things Out: Bidirectional Signaling of the Cell-ECM Interface, Implications in the Mechanobiology of Cell Spreading, Migration, Proliferation, and Differentiation
Q34731498Genetic effects on postprandial variations of inflammatory markers in healthy individuals
Q34623513Genetic variants associated with circulating MMP1 levels near matrix metalloproteinase genes on chromosome 11q21-22 in Taiwanese: interaction with obesity.
Q87881232Genetic variants of the matrix metalloproteinase family genes and risk for hypertension: a case-control study among northeastern Han Chinese
Q33572465Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels
Q42053870High glucose and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity
Q34437265High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome
Q35803849Hispolon inhibits TPA-induced invasion by reducing MMP-9 expression through the NF-κB signaling pathway in MDA-MB-231 human breast cancer cells
Q44810471Identifying the regulative role of NF-κB binding sites within promoter region of human matrix metalloproteinase 9 (mmp-9) by TNF-α induction
Q42972140Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques.
Q53589745Immunohistochemical analysis on MMP-2 and MMP-9 for wound age determination.
Q48228211Increased Levels of Soluble Cluster of Differentiation 40 Ligand, Matrix Metalloproteinase 9, and Matrix Metalloproteinase 2 Are Associated with Carotid Plaque Vulnerability in Patients with Ischemic Cerebrovascular Disease
Q64092518Integrative Analysis Revealing Human Adipose-Specific Genes and Consolidating Obesity Loci
Q37456901Intracellular regulation of matrix metalloproteinase-2 activity: new strategies in treatment and protection of heart subjected to oxidative stress
Q36302470Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome
Q28395449MMP-2 and TIMP-1 predict healing of WTC-lung injury in New York City firefighters
Q33820443MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study
Q35529307MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK.
Q50916304Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Q47223491Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease
Q36542806Matrix metalloproteases and PAR1 activation
Q39414242Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-α.
Q35107715Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo
Q42988559Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis.
Q36009930Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease
Q37380847Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.
Q38014069Matrix metalloproteinases
Q37224482Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD.
Q36081593Matrix metalloproteinases and diabetic vascular complications.
Q46060562Matrix metalloproteinases and membrane damage markers in sera of patients with acute myocardial infarction
Q37559372Matrix metalloproteinases and peripheral arterial disease
Q36477722Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
Q35733486Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
Q38024303Matrix metalloproteinases: a review of their structure and role in systemic sclerosis
Q36752100Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability
Q35750269Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties
Q51475687Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.
Q51128003Molecular dynamics simulation study on the interaction of collagen-like peptides with gelatinase-A (MMP-2).
Q37557366Molecular imaging in cardiovascular disease: targets and opportunities
Q38648056Neutrophil proteolytic activation cascades: a possible mechanistic link between chronic periodontitis and coronary heart disease
Q39138216New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis.
Q51730474New methods to image unstable atherosclerotic plaques.
Q26861815Novel mechanistic and clinical implications concerning the safety of statin discontinuation
Q47099030Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells
Q35103192Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbits
Q46863979Oxidized HDL induces cytotoxic effects: implications for atherogenic mechanism
Q36634707Polymorphisms in matrix metalloproteinases MMP1 and MMP9 are associated with primary open-angle and angle closure glaucoma in a Pakistani population.
Q54968783Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein.
Q35048514Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031.
Q38850914Prospects for the therapeutic application of sulfated polysaccharides of brown algae in diseases of the cardiovascular system: review
Q53668219Proteomic profiling of acute coronary thrombosis reveals a local decrease in pigment epithelium-derived factor in acute myocardial infarction.
Q55041980Pterostilbene Inhibits Vascular Smooth Muscle Cells Migration and Matrix Metalloproteinase-2 through Modulation of MAPK Pathway.
Q30577193Radiolabelled probes for imaging of atherosclerotic plaques.
Q36140890Recent findings on the role of gelatinases (matrix metalloproteinase-2 and -9) in osteoarthritis
Q36882229Regulation of MMP-9 by p53 in first trimester cytotrophoblastic cells
Q34702697Retinal pigment epithelium protection from oxidant-mediated loss of MMP-2 activation requires both MMP-14 and TIMP-2.
Q36567357Role of matrix metalloproteinase-8 in atherosclerosis
Q51835885Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 -1612 5A/6A promoter genotype and associated with myocardial infarction.
Q51097392Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome.
Q42423089Squaric acid-based peptidic inhibitors of matrix metalloprotease-1.
Q37639014TIMP1 and MMP9 are predictors of mortality in septic patients in the emergency department and intensive care unit unlike MMP9/TIMP1 ratio: Multivariate model
Q36304170Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging
Q45190630Temporal expression of metalloproteinase-8 and -13 and their relationships with extracellular matrix metalloproteinase inducer in the development of ligature-induced periodontitis in rats
Q55471070The Role of Matrix Metalloproteinase-3 In the Development of Atherosclerosis and Cardiovascular Events.
Q51770077The development of cardiac fibrosis in low tissue factor mice is gender-dependent and is associated with differential regulation of urokinase plasminogen activator.
Q36831073The downstream regulation of chemokine receptor signalling: implications for atherosclerosis
Q43873018The effect of prolonged systemic doxycycline therapy on serum tissue degrading proteinases in coronary bypass patients: a randomized, double-masked, placebo-controlled clinical trial
Q46790428The highly specific platelet glycoprotein (GP) VI agonist trowaglerix impaired collagen-induced platelet aggregation ex vivo through matrix metalloproteinase-dependent GPVI shedding.
Q35013868The pathophysiology of obesity and its clinical manifestations
Q38273202The significance of matrix metalloproteinases in parasitic infections involving the central nervous system
Q35744631The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach
Q43296924Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction
Q37413679Type I interferon modulates monocyte recruitment and maturation in chronic inflammation
Q38068594Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology
Q36422755Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy
Q37088243Vascular actions of estrogens: functional implications
Q36271838Venous hypertension and the inflammatory cascade: major manifestations and trigger mechanisms

Search more.